Evidence map›Paper›PMID 36851435›Full record

ArticleVeterinary sciences2023

Antioxidant Effect of a Dietary Supplement Containing Fermentative S-Acetyl-Glutathione and Silybin in Dogs with Liver Disease.

Elisa Martello, Francesca Perondi, Donal Bisanzio, Ilaria Lippi, Giorgia Meineri, Valeria Gabriele

Open access · goldAbstract read
In one paragraph

Article in Veterinary sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Effects ofVeterinary sciences · 2025
    Article
  3. Article
  4. Oxidative Stress in Canine Diseases: A Comprehensive Review.Antioxidants (Basel, Switzerland) · 2024
    Review
  5. Supplementation withAnimals : an open access journal from MDPI · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Elisa MartelloDivision of Epidemiology and Public Health, School of Medicine, University of Nottingham, Nottingham NG 1PB, UK.ORCID 0000-0003-0247-6670
Francesca PerondiDepartment of Veterinary Science, University of Pisa, San Piero a Grado, 56122 Pisa, Italy.ORCID 0000-0003-4703-7559
Donal BisanzioRTI International, Washington, DC 20005, USA.
Ilaria LippiDepartment of Veterinary Science, University of Pisa, San Piero a Grado, 56122 Pisa, Italy.ORCID 0000-0002-3595-6067
Giorgia MeineriDepartment of Veterinary Sciences, University of Turin, Largo Paolo Braccini, 10095 Grugliasco, Italy.
Valeria GabrieleCandioli Pharma S.R.L., S.da Antica di None, 10092 Beinasco, Italy.
University of Pisa · ITRTI International · USUniversity of Nottingham · GBUniversity of Turin · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oxidative stress is often involved in liver disease progression. Liver is the primary site for the synthesis of glutathione (GSH), the major intracellular antioxidant. GSH erythrocyte concentration can decrease in case of liver damage. So, the use of food supplements with antioxidant capacity has been reported in the veterinary literature. In this case-control study, we tested a new supplement containing S-acetyl-glutathione (SAG), silybin, and other antioxidant ingredients in dogs affected by liver disease. After two weeks of supplement administration, we were able to report a significant increase in the level of erythrocyte GSH in the treated (TRT) group, nearly reaching the physiological limit at the end of the study. In addition, most of the key liver parameters are significantly reduced in the TRT group by the end of the trial. The results of this study support the effectiveness of the tested complementary feed, which may be helpful in managing dogs with liver conditions.

Indexed as

dogGSHliver diseaseoral administrationoxidative stress

Identifiers

PMID36851435
PMCPMC9966841
OpenAlexW4319600326

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.